Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Overview of attention for article published in BMC Cancer, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 15 X posts from 13 X users, with an upper bound of 15,543 followers.

RT @_sarahweller: THIS! JUST OUT: "Fitness for treatment in adv prostate cancer pops remains a significant barrier to accessing therapies f…

RT @_sarahweller: THIS! JUST OUT: "Fitness for treatment in adv prostate cancer pops remains a significant barrier to accessing therapies f…

RT @_sarahweller: THIS! JUST OUT: "Fitness for treatment in adv prostate cancer pops remains a significant barrier to accessing therapies f…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.